AIN
Improving Neonatal ICU

Improving Neonatal ICU

location_on Denmark

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

We develop and supply advanced continuous oxygen monitoring systems designed for intensive care units, enabling improved patient safety and more precise clinical decision-making. These significantly reduce complications caused by hyperoxia and hypoxia for neonatal ICU patients.

Highlights

  • We lower the risk for functional disorders and mortality for preterm babies
  • We increase quality of life for individuals and family members
  • We save huge societal costs
  • Our products meets clinical demands on a global scale
  • Our sensor technology is IPR protected in the US and in Europe

Overview

Target CN¥ 5,000,000
Minimum CN¥ 425,000
Investment Raised CN¥ 850,000
Previous Rounds CN¥ 650,000
Stage MVP/Finished Product
Investor Role Any

Ask a question
Got a question about this project?

Similar Projects